abbreviated new drug application

By Memorandum Order entered by the Honorable Leonard P. Stark in Cumberland Pharmaceuticals Inc. v. InnoPharma, Inc., Civil Action No. 12-618-LPS (D.Del., November 1, 2013), the Court granted Defendant
Continue Reading Judge Stark Grants Defendant InnoPharma’s Motion to Dismiss Complaint of Patent Infringement in ANDA Action

By Claim Construction Opinion entered in The Medicines Company v.Teva Parenteral Medicines, Inc. et al., C.A. No. 09-750-RGA (D.Del., July 11, 2013), The Honorable Richard G. Andrews construed three disputed
Continue Reading Judge Andrews Issues Markman Opinion Construing Three Terms in Dispute in ANDA Action filed by The Medicines Company

By Opinion issued by The Honorable Sue L. Robinson in Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc., et al., Civil Action No. 09-286-SLR (D.Del., May 29, 2012)

Continue Reading Following Seven Day Bench Trial, Judge Robinson Finds Plaintiff Pronova Did Prove Infringement of Its ‘667 and ‘077 Patents by Defendants in ANDA Action

By Memorandum Opinion entered by The Honorable Richard G. Andrews in Shire LLC, et al. v. Teva Pharmaceuticals USA Inc., et al., Civil Action No. 10-329-RGA (D.Del., March 22

Continue Reading Judge Andrews Issues Claim Construction Ruling on Disputed Terms of Patents Covering Drug Used to Treat Pediatric ADHD

By Memorandum Opinion entered by the Honorable Gregory M. Sleet in AstraZeneca LP, et al. v. Mylan Pharmaceuticals Inc., Civil Action No. 08-53-GMS (D.Del., June 23, 2011) after a three

Continue Reading Chief Judge Sleet Concludes that Mylan’s Proposed ANDA Product Does Not Infringe the Patent-In-Suit Asserted by AstraZeneca and Others

By Order dated June 24, 2010, Chief Judge Gregory M. Sleet adopted the Report and Recommendation Regarding Claim Construction entered by Magistrate Judge Leonard P. Stark on May 12, 2010

Continue Reading Chief Judge Sleet Adopts Magistrate Judge Stark’s Report and Recommendation on Claim Construction